|Articles|May 11, 2021
Nitrosamine impurities in Sartan drug products by GC-MS/MS
Author(s)Shimadzu Corporation
This application demonstrates a reliable GC–MS/MS method for analysis of nitrosamine drug products including the three impurities NDMA, NDEA, and NDBA listed by US FDA.
Related Content
Trending on LCGC International
1
How AI and Machine Learning Are Reshaping Separations Science at HPLC 2026
2
GC-MS & GC-IMS Reveal Black Tea Aroma Secrets
3
GC-MS Detection of Microbes in Spacecraft Water
4
Best of the Week: Chromatography Methods, HPLC 2026 Previews, and More
5